Terms: = Thyroid cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28 AND Prognosis
3 results:
1. Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma.
Makino H; Notsu M; Asayama I; Otani H; Morita M; Yamamoto M; Yamauchi M; Nakao M; Miyake H; Araki A; Uchino S; Kanasaki K
Intern Med; 2022 Nov; 61(22):3383-3390. PubMed ID: 35370235
[TBL] [Abstract] [Full Text] [Related]
2. Parathyroid cancer: An update.
Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
[TBL] [Abstract] [Full Text] [Related]
3. The surgical strategy and the molecular analysis of patients with parathyroid cancer.
Enomoto K; Uchino S; Ito A; Watanabe S; Shibuya H; Enomoto Y; Noguchi S
World J Surg; 2010 Nov; 34(11):2604-10. PubMed ID: 20480190
[TBL] [Abstract] [Full Text] [Related]
